THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

Screening for prostate cancer using a blood test likely reduces the risk of dying from prostate cancer and may also reduce the risk of dying from any cause. Screening likely makes little to no ...

A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...

A new study suggests that prostate cancer screening could reduce deaths by 13 per cent, as cancer experts in the UK assess ...

Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...

Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment ...

New blood test could show if prostate cancer treatment is failing - The discovery could lead to personalised treatments for ...

Former President Joe Biden last underwent a Prostate-Specific Antigen (PSA) blood test, one of the most common ways to screen for prostate cancer, in 2014 while he was serving as Barack Obama’s vice ...

Medicare covers one annual prostate-specific antigen (PSA) test for people with prostates if they meet the eligibility guidelines and the test is medically necessary. Medicare typically covers one ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...